|
XILINX,
INC. |
|
|
|
|
|
|
|
CONSOLIDATED CONDENSED
BALANCE SHEETS (Thousands) |
|
|
|
|
|
|
|
|
|
|
June 27, |
|
March 28, |
|
|
|
|
1998 |
|
1998 |
|
|
|
|
(Unaudited) |
|
(Audited) |
|
|
|
|
|
|
|
Current
assets |
|
|
|
|
|
|
Cash,
cash equivalents and short term investments |
|
|
|
$
361,634 |
|
$
362,187 |
Accounts
receivable |
|
|
|
77,870 |
|
60,912 |
Inventories |
|
|
|
56,458 |
|
55,289 |
Advances
for wafer purchases |
|
|
|
70,836 |
|
72,267 |
Deferred
income taxes and other current assets |
|
|
|
54,190 |
|
49,569 |
|
|
|
|
|
|
|
Total
current assets |
|
|
|
620,988 |
|
600,224 |
|
|
|
|
|
|
|
Property,
plant and equipment, net |
|
|
|
89,062 |
|
88,276 |
Restricted
investments |
|
|
|
36,749 |
|
36,271 |
Investment
in joint venture |
|
|
|
86,146 |
|
90,872 |
Advances
for wafer purchases |
|
|
|
63,214 |
|
77,342 |
Developed
technology and other assets |
|
|
|
47,659 |
|
48,253 |
|
|
|
|
|
|
|
Total
assets |
|
|
|
$
943,818 |
|
$
941,238 |
|
|
|
|
|
|
|
Current
liabilities |
|
|
|
|
|
|
Accounts
payable and accrued liabilities |
|
|
|
$
68,493 |
|
$
69,759 |
Deferred
revenue on shipments to distributors |
|
|
|
64,558 |
|
55,898 |
|
|
|
|
|
|
|
Total
current liabilities |
|
|
|
133,051 |
|
125,657 |
|
|
|
|
|
|
|
Long-term
debt |
|
|
|
250,000 |
|
250,000 |
Deferred
tax liabilities |
|
|
|
17,802 |
|
15,406 |
Stockholders'
equity |
|
|
|
|
|
|
Common
stock and additional paid-in capital |
|
|
|
112,754 |
|
119,901 |
Retained
earnings |
|
|
|
531,497 |
|
504,468 |
Treasury
stock, at cost |
|
|
|
(81,930) |
|
(56,973) |
Cumulative
translation adjustment |
|
|
|
(19,356) |
|
(17,221) |
|
|
|
|
|
|
|
Total
stockholders' equity |
|
|
|
542,965 |
|
550,175 |
|
|
|
|
|
|
|
Total
liabilities and stockholders' equity |
|
|
|
$
943,818 |
|
$
941,238 |